The table below shows Structure Therapeutics Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Operating cash flow
$15.23M
-$52.23M
-$34.08M
-$20.31M
-$13.52M
Capital expenditure
$1.18M
$314.00K
$162.00K
-
$65.00K
Investing cash flow
-$496.95M
$34.03M
$1.42M
-$49.02M
-$39.72M
Dividends paid
-
-
-
-
-
Stock buybacks
-
-
GPCR operating cash flow (10-K history)
Structure Therapeutics Inc. reported operating cash flow of -$222.20M for fiscal year 2025. That is down 90.5% from -$116.64M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.